Other OTC - Delayed Quote USD

CaliPharms, Inc. (KGET)

0.0000 0.0000 (0.00%)
At close: April 18 at 3:55 PM EDT
Currency in USD All numbers in thousands
Download
Breakdown
TTM
Total Revenue
112.4650
Cost of Revenue
143.0310
Gross Profit
-30.5660
Operating Expense
714.7400
Operating Income
-745.3060
Net Non Operating Interest Income Expense
-2,590.2150
Pretax Income
-6,308.8480
Net Income Common Stockholders
-6,308.8480
Diluted NI Available to Com Stockholders
-6,308.8480
Total Operating Income as Reported
-745.3060
Total Expenses
857.7710
Net Income from Continuing & Discontinued Operation
-6,308.8480
Normalized Income
-6,308.8480
Interest Expense
2,590.2150
Net Interest Income
-2,590.2150
EBIT
-3,718.6330
EBITDA
-3,718.6330
Reconciled Cost of Revenue
143.0310
Net Income from Continuing Operation Net Minority Interest
-6,308.8480
Normalized EBITDA
-3,718.6330
-
Yahoo Finance Plus Essential access required. Unlock Access